FEN1 (Flap Endonuclease 1) is a key DNA repair enzyme essential for DNA replication and repair processes[@liu2000]. As a structure-specific nuclease, FEN1 processes flap structures during DNA replication and repair. Dysregulation of FEN1 has been strongly implicated in neurodegeneration, cancer predisposition, and aging[@mastroeni2018].
Molecular Function
DNA Repair Enzymatic Activity
FEN1 possesses multiple enzymatic functions essential for genome stability:
Flap endonuclease activity: Cleaves flap structures that form during DNA replication
5' exonuclease activity: Removes RNA-DNA primers during Okazaki fragment processing
FEN1 (Flap Endonuclease 1) is a key DNA repair enzyme essential for DNA replication and repair processes[@liu2000]. As a structure-specific nuclease, FEN1 processes flap structures during DNA replication and repair. Dysregulation of FEN1 has been strongly implicated in neurodegeneration, cancer predisposition, and aging[@mastroeni2018].
Molecular Function
DNA Repair Enzymatic Activity
FEN1 possesses multiple enzymatic functions essential for genome stability:
Flap endonuclease activity: Cleaves flap structures that form during DNA replication
5' exonuclease activity: Removes RNA-DNA primers during Okazaki fragment processing
FEN1's catalytic activities are mediated by conserved domains:
N-terminal domain: Contains the active site for nuclease activity
Intermediate domain: Involved in substrate binding
C-terminal helix-hairpin-helix (HhH) domain: Coordinates metal ions for catalysis
Role in Neurodegenerative Diseases
Alzheimer's Disease
FEN1 dysfunction significantly contributes to Alzheimer's disease pathogenesis:
DNA Damage Accumulation: Impaired FEN1 activity leads to accumulation of DNA damage in [neurons](/entities/neurons), accelerating neurodegeneration[@mastroeni2018]. Neurons are particularly vulnerable due to their post-mitotic state.
Genomic Instability: FEN1 deficiency promotes chromosomal instability that may contribute to [tau](/proteins/tau) pathology and neuronal dysfunction.
Cell Cycle Re-entry: DNA damage signaling due to FEN1 dysfunction can trigger inappropriate cell cycle re-entry in neurons, leading to [apoptosis](/entities/apoptosis).
Mitochondrial Dysfunction: FEN1 mutations affect mitochondrial DNA repair, compounding mitochondrial dysfunction in AD.
Parkinson's Disease
In Parkinson's disease, FEN1 plays a protective role:
Dopaminergic Neuron Survival: FEN1 activity is crucial for maintaining genomic integrity in dopaminergic neurons, which are particularly vulnerable to oxidative stress.
[α-Synuclein](/proteins/alpha-synuclein) Interactions: DNA damage can promote α-synuclein aggregation, and FEN1 dysfunction may accelerate this process[@wong2019].
Mitochondrial DNA Repair: FEN1 deficiency in mitochondria promotes accumulation of mitochondrial DNA mutations in dopaminergic neurons.
Amyotrophic Lateral Sclerosis
FEN1 involvement in ALS includes:
Motor Neuron Vulnerability: FEN1 dysfunction exacerbates DNA damage accumulation in motor neurons.
Oxidative Stress: The high metabolic demand of motor neurons makes them particularly sensitive to FEN1 deficiency under oxidative stress conditions.
RNA Processing: FEN1's role in processing R-loops may affect RNA metabolism relevant to [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology.
DNA Damage Response in Neurodegeneration
FEN1 sits at the nexus of DNA damage response and neurodegeneration:
DNA Damage Signaling: FEN1 deficiency activates DNA damage response pathways including p53, ATM/ATR
Apoptosis: Persistent DNA damage triggers neuronal apoptosis through multiple pathways
Cellular Senescence: FEN1 dysfunction can promote cellular senescence in supporting glial cells
Cancer Predisposition
FEN1 mutations cause cancer predisposition syndromes:
FEN1 Mutations: Certain FEN1 variants increase cancer risk, particularly breast and ovarian cancer
Genome Instability: FEN1 deficiency promotes mutagenic DNA repair
Therapeutic Implications: FEN1-targeting therapies show promise in cancer treatment
Therapeutic Targeting
FEN1-based therapeutic strategies include:
DNA Repair Enhancement: Developing FEN1 activators to enhance DNA repair in neurons
Synthetic Lethality: Exploiting FEN1 deficiency in cancer therapy
Neuroprotection: Small molecules that compensate for FEN1 dysfunction
Research Directions
Key research areas include:
Understanding FEN1 regulation in post-mitotic neurons
Developing FEN1 activity modulators
Biomarker development for DNA repair deficiency
Clinical translation of neuroprotective strategies
[Liu Y, et al., Human FEN1: structure, function, and application in DNA repair. Gene. 2000 (2000)](https://pubmed.ncbi.nlm.nih.gov/10817793/)
[Mastroeni D, et al., DNA damage in Alzheimer's disease and neurodegeneration. Journal of Alzheimer's Disease. 2018 (2018)](https://pubmed.ncbi.nlm.nih.gov/29562546/)
[Wong A, et al., Alpha-synuclein and DNA damage: a vicious cycle in Parkinson's disease. Brain Research. 2019 (2019)](https://pubmed.ncbi.nlm.nih.gov/30690185/)
[Unknown, Caldecott KW. DNA single-strand break repair and neurodegeneration. DNA Repair. 2004 (2004)](https://pubmed.ncbi.nlm.nih.gov/15317851/)